ID   B72.3
AC   CVCL_G097
DR   CLO; CLO_0001828
DR   ABCD; ABCD_AJ341
DR   ATCC; HB-8108
DR   Wikidata; Q54752829
RX   Patent=US4522918;
RX   PubMed=3396010;
RX   PubMed=6789331;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8108.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human tumor-associated glycoprotein 72 (TAG-72) (CA72-4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
RX   Patent=US4522918;
RA   Schlom J., Colcher D., Nuti M., Hand P.H., Austin F.;
RT   "Process for producing monoclonal antibodies reactive with human
RT   breast cancer.";
RL   Patent number US4522918, 11-Jun-1985.
//
RX   PubMed=3396010;
RA   Muraro R., Kuroki M., Wunderlich D., Poole D.J., Colcher D., Thor A.,
RA   Greiner J.W., Simpson J.F., Molinolo A.A., Noguchi P.D., Schlom J.;
RT   "Generation and characterization of B72.3 second generation monoclonal
RT   antibodies reactive with the tumor-associated glycoprotein 72
RT   antigen.";
RL   Cancer Res. 48:4588-4596(1988).
//
RX   PubMed=6789331; DOI=10.1073/pnas.78.5.3199;
RA   Colcher D., Hand P.H., Nuti M., Schlom J.;
RT   "A spectrum of monoclonal antibodies reactive with human mammary tumor
RT   cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 78:3199-3203(1981).
//